Article
Single-cell and spatially resolved atlas of pancreatic cancer reveals immunophenotypes associated with clinical outcome
2025-02-10
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC), accounting for 90% of pancreatic neoplasms, is characterized by its poor prognosis, with a 5-year survival rate of only 12%. Most patients are diagnosed with metastatic or locally advanced disease, leaving only 15% eligible for curative resection. PDAC exhibits resistance to chemotherapy, targeted therapies, and immunotherapy, largely due to its highly heterogeneous tumor m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e59abcda-00b7-5680-9fbb-92125ab9a04c
- DOI
- 10.1101/2025.02.08.637283
